Background: CHADS2 and CHA2DS2-VASc scores are widely used in clinical practice and include similar risk factors for the development of coronary artery disease (CAD). It is known that the factors comprising the newly defined CHA2DS2-VASc-HSF score promote atherosclerosis and are associated with severity of CAD.
Aim: To investigate the association of the CHA2DS2-VASc-HSF score with the severity of CAD as assessed by SYNTAX score (SxS) in patients with ST segment elevation myocardial infarction (STEMI).
Methods: A total of 454 consecutive patients with STEMI (males 79%, mean age 57.3 ± 12.9 years), who underwent primary percutaneous coronary intervention were included in our study. The patients were divided into three groups according to the SxS tertiles: low SxS group (SxS < 14; 151 patients), intermediate SxS group (SxS 14-20; 152 patients), and high SxS group (SxS ≥ 21; 151 patients).
Results: The CHADS2, CHA2DS2-VASc, and CHA2DS2VASc-HSF scores were found to be significantly different among the SxS groups (p < 0.001, p < 0.001, and p < 0.001). After multivariate analysis, the CHA2DS2-VASc-HSF score was associated with high SxS (odds ratio [OR] 1.258, 95% confidence interval [CI] 1.026-1.544; p = 0.028) together with age (OR 1.032, 95% CI 1.013-1.050; p = 0.001) and ejection fraction (OR 0.927, 95% CI 0.901-0.955; p < 0.001).
Conclusions: A newly diagnosed CHA2DS2-VASc-HSF score predicts the severity of atherosclerosis in patients with STEMI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5603/KP.a2016.0054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Coronary artery disease severity and risk stratification of patients with non ST-elevation acute coronary syndrome using CHADS-VASc-HSF score.
BMC Cardiovasc Disord
May 2024
Cardiovascular Medicine Department, Assiut University Heart Hospital, Assiut University, Assiut, 71526, Egypt.
Article Synopsis
- - This study investigated how well the CHADS-VASc-HSF score can predict the severity of coronary artery disease (CAD) and the risk of major adverse cardiovascular events (MACE) in patients with non-ST elevation acute coronary syndrome (NSTE ACS) who don't have atrial fibrillation.
- - It included 200 patients, primarily male, and categorized them into groups based on their CHADS-VASc-HSF scores; higher scores were associated with more severe CAD as measured by the Syntax score (SS).
- - The findings showed that the CHADS-VASc-HSF score is a strong predictor for both severe CAD and MACE, with certain cutoff points demonstrating high sensitivity and specificity, highlighting its potential clinical
Prediction of Coronary Artery Disease Severity by Using CHA2DS2-VASC-HSF Score in Patients with ST-Elevation Myocardial Infarction.
Mymensingh Med J
April 2023
Dr Mohammad Abdur Rahim, MD, Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh; E-mail:
CHADS₂ and CHA₂DS₂-VASc scores are widely used in clinical practice and include similar risk factors for the development of coronary artery disease (CAD). It is known that the factors comprising the newly defined CHA₂DS₂-VASC-HSF score promote atherosclerosis and associated with severity of CAD. Objective of the study was to find out the association of the CHA₂DS₂-VASC-HSF score with the severity of CAD in patients with ST elevation myocardial infarction (STEMI).
View Article and Find Full Text PDFPredictive Value of CHADS -VASc-HSF Score for Severity of Acute Coronary Syndrome.
Clin Appl Thromb Hemost
March 2022
117914Chengde Medical University Affiliated Hospital, Chengde, HeBei, 067000, China.
CHADS and CHADS-VASc scores have been used to assess the prognostic risk of thromboembolism in non-valvular atrial fibrillation patients. Recent studies have shown the utility of CHADS and CHADS-VASc scores for evaluating the severity of coronary artery disease (CAD). The newly defined CHADS-VASc-HSF score evaluates atherosclerosis and is associated with CAD severity.
View Article and Find Full Text PDFCHA2DS2-VASc-HSF Score may Better Predict the Development of Total Coronary Artery Occlusion in Acute Coronary Syndrome.
Angiology
April 2022
The Department of Cardiology, Acıpayam State Hospital, Denizli, Turkey.
New CHADS-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
BMC Cardiovasc Disord
July 2020
Department of Cardiology, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110004, Liaoning, China.
Background: The no-reflow phenomenon (NRP) is a serious complication of primary percutaneous coronary intervention (PPCI) and is an independent predictor of poor prognosis. We aimed to find a simple but effective risk stratification method for the prediction of NRP.
Methods: This retrospective single-center study included 454 consecutive patients diagnosed with acute ST-segment elevation myocardial infarction (STEMI) and treated by PPCI, who were admitted to our emergency department between January 2017 and March 2019.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!